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1. Introduction  
During the past decade, Endovenous Laser Ablation (EVLA) has been introduced as a 
minimally invasive alternative to high ligation and open surgical stripping of the 
incompetent Great Saphenous Vein (GSV) or Short Saphenous Vein (SSV). There is great 
variability in EVLA protocols and at the present time there is data from more than 60 
publications with more than 15000 EVLA treatments reporting good clinical results but also 
undesired side effects. Post-operative pain in the operated area is rated from slight to 
moderate by most patients (81, 5%),post-operative induration of the truncal vein can be 
expected in 78, 1% of patients and perivenous ecchymosis and hematoma are observed in an 
average of 52% of patients. Further complications such as persistent dysesthesia after nerve 
lesions (0, 8%) and burns on the skin (0, 2%) are reported in a minority of cases. Great care 
must be taken to ensure adequate tumescent anesthesia and light dosimetry in order to 
avoid post-operative paresthesia.  
Thrombus propagation to the deep venous system (0, 2%) or pulmonary embolism (0, 02%) 
are seldom observed. Careful sonografic examination of the sapheno-femoral or sapheno - 
popliteal junctions is required during the procedure. Inappropriate energy densities can 
lead to side effects such as transmural ablations, perforations and alteration in perivenous 
tissue. So far it has not been possible to establish general valid recommendations for 
appropriate energy density nevertheless it seems clear that the use of laser systems with 
longer wavelengths will lead to a reduction of undesired tissue side effects.  
2. Endovenous laser therapy  
The first application of endoluminal laser was described by Bone in 1999 (Bone, 1999). EVLA 
received Food and Drug Administration approval in January 2002 and acts through a 
mechanism of nontrombotic venous occlusion of the target vein through the delivery of 
laser energy into the vein lumen via a laser fiber. Laser (light amplification by stimulated 
emission of radiation) creates high-energy bundled light that is monochromatic (of an 
unique wavelength) and releases direct thermal energy that heats both the blood and 
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adjacent vein wall (Van den Bos et al. 2008).The tip fiber reaches temperatures in the 
region of 800ºC. This results in destruction of the intima, collagen denaturation of the 
media and eventually fibrotic occlusion of the vein. Lasers with wavelengths of 810, 940, 
980 (haemoglobin specific) and 1319, 1320 and 1470 nm (water specific) have been 
successfully used. The light of these wavelengths are not visible to the human eye and for 
orientation purposes, visible light is additionally emitted as a pilot beam. In the last ten 
years EVLA has evolved into an accepted option for the treatment of underlying truncal 
vein reflux causing varicose veins.  
2.1 Preoperative duplex imaging 
Duplex ultrasound has become the reference standard in assessing the morphology and 
hemodynamics of the lower limb veins. Preoperative duplex planning for EVLA is 
extremely important in order to avoid potential complications. Almost all modern 
ultrasound scanners used for imaging peripheral venous disease should be suitable for 
preoperative imaging and for guiding endovenous procedures. Typically linear array 
transducers with a frequency in the range of 5-12 MHz are suitable. During this examination 
it is important to evaluate the anatomy and the physiology of both the superficial and deep 
venous systems. EVLA is a good treatment option for eliminating reflux in a straight 
superficial venous segment. Indications for ablation include reflux in a truncal vein of a 
duration greater than 0, 5 seconds, that is responsible for patient symptoms or skin changes. 
Measurement of the vein diameter should be carried out during the course of pre-operative 
ultrasound for the calculation of the appropriate energy density. The duplex ultrasound 
inclusion criteria for this treatment are: veins with a 2mm or more diameter but preferably 
with 3mm or more and a treatable length of at least 10-12 cm. The course of the saphenous 
vein, from the saphenofemoral or saphenopopliteal junction to the insertion site is mapped 
by ultrasound. An indelible marking pen is used to mark incompetent sources of venous 
reflux under duplex ultrasound guidance before the procedure (figure 1).  
 
Fig. 1. Pre-operative marking of the vein, topic anesthesic on the length of the vein being 
treated 
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Veins with acute thrombophebitis or partially obstructed saphenous vein on the duplex 
examination are exclusion criteria for this kind of treatment. Patients with ropy varicose 
veins located immediately under the skin or those with aneurismal dilations of the sapheno-
femoral junction are probably better served with conventional surgery( Gloviczki et al 
2011).The use of EVLA to close incompetent perforating veins has been described. At this 
point, the indications and contraindications,  as well as the success rates and safety of this 
approach have only recently begun to be evaluated (Proebstle et al 2009). The use of EVLA 
to directly close surface varicose veins is not encouraged. These veins are usually too 
tourtous for current generation devices to pass through. Also these veins are very 
superficial; EVLA of these veins carries a high risk of thermal skin injury.  
2.2 The procedure 
EVLA begins with ultrasound evaluation and disinfection of the skin. The area to be 
operated on is covered with sterile dressings. The groin area  has to be accessible as a 
sonographic examination of the sapheno-femoral junction is required. In addition, an intra-
operative switch to conventional open surgery with high ligation and stripping must be 
possible if necessary. The patient is placed in the reverse Trendelenburg position and an 
insertion site is chosen to maximize the treatment length. For GSV, this is around the knee 
level where the vein is usually superficial, the portion below the knee beeing in close 
proximity to the saphenous nerve carrying an increased risk of parestesia from the puncture 
or thermal nerve injury by the laser energy delivered. 
After infiltration with local anesthetic at the insertion site, an introducer needle is inserted 
into the vein or a small incision is made and the vein is elevated with a phlebotomy hook. 
Although efficient this second approach is not preferred because of the increased risk of 
trauma or venospasm. A microguidewire is inserted into the vein, followed by the 
placement of a 4F microsheath. With the help of a floopy guidewire, the sheath is exchanged 
for a 5F sheath. The wire is advanced so it that runs across the SFJ, always with ultrasound 
guidance. It is not uncommon for the wire to loop, especially in dilated areas of the vein. 
The laser fiber is then introduced through the sheath into the GSV or SSV and advanced 
proximally to the SFJ or SPJ. The fiber tip extends proximaly 1-2 cm beyond the end of the 
sheath, and its position should be marked. This is important since the fiber tip can be heated 
up to several hundred degrees Celsius during the procedure and if there is no sufficient 
distance between them, this can lead to the melting of the sheath material. To treat reflux of 
the GSV beginning at the SFJ, the device is generally positioned just below the junction of a 
competent epigastric vein. Theoretically this preservers flow at the junction and prevents 
thrombus from extending upwards. For SSV ablation, the tip of the device is positioned just 
beyond the take-off point of a gastrocnemius vein. If this vein is not identified by ultrasound 
evaluation, ablation generally begins at the cephalic end of the intrafascial SSV before it 
passes below the muscular fascia. 
Once the device is appropriately placed for ablation, the patient is placed in Trendelenburg 
position to facilitate vein emptying and perivenous tumescent anesthesia is then delivered. 
Optimal delivery of this fluid into the saphenous space is accomplished with real time 
duplex ultrasound examination. The tumescence has four main goals; firstly it provides 
cooling and offers some perivascular tissue protection against heating or burns. Secondly it 
provides pain relief. Thirdly, the vein tends to collapse, removing blood and improving 
surface contact between the laser and the vein wall and finally it will ensure that there is at 
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least 1 cm between the vein and the skin surface to avoid skin burns. Once the vein is 
surrounded by tumescence, the position of the laser tip must be rechecked to ensure it has 
not been accidentally displaced. The thermal energy is then delivery using protocols 
inherent to each device (Table 1). Currently 50 to 80 J/cm is the average treatment energy 
most often used for EVLA procedures. 
 
Laser Generators Wavelength Recommended Pullback 
Diomed 810 nm 1 cm every 3-5 seconds 
Varilaser 810 nm 50-70 J/cm 
Dornier 940 nm 1 cm every 3-5 seconds 
AngioDynamics 980 nm 50-80 J/cm 
Sciton 1319 nm Unknown 
Cool Touch 1320 nm Automated fiber pullback device at 1 mm/second 
Biolitec 1470 nm UnKnown 
Table 1. Endolaser Ablation Devices 
The goal is to achieve successful ablation while at the same time minimizing the incidence of 
postoperative pain and bruising. 
Ultrasound should be used to follow the catheter pullback, the energy supplied to the laser 
tip also heats the surrounding blood and this can be clearly seen as echogenic areas. 
At the end of the procedure, ultrasound can then be used to ensure the patency of the 
common femoral vein, and to confirm successful obliteration of the saphenous vein. Its 
lumen is usually reduced and filled with strongly echoing thrombus material. 
If a patent segment is identified, re-treatment is advisible. 
Ancillary ambulatory phlebectomy or sclerotherapy may be performed immediately after 
the EVLA procedure or several weeks later to treat any residual branch varicose veins 
(figure 2). 
2.3 Post-procedural care 
The entry site is covered with a SteryStrip bandage as well as the phlebectomy sites, if 
performed. Graduated compression stockings with an ankle pressure of 30-40 mmHg or an 
elastic wrap is placed on the limb at the end of the procedure and should be kept at least one 
week after the procedure. (Figure 3) 
Immediately following EVLA, patients are instructed to ambulate regularly to promote the 
vessel occlusion process and decrease the incidence of deep venous thrombosis (DVT). But 
vigorous exercise is generally discouraged for the first week.  
There is no convincing data to support the routine use of anticoagulants with EVLA. 
Selected patients with a history of thrombophlebitis, DVT, or obesity are candidates for 
thrombosis prophylaxis (Geerts et al 2008). In Europe the use of a short course of post 
procedural prophylactic dose of low molecular weight heparin is common (Proebstle 2003). 
The complication rate following its use does not seem substantially increased. 
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Fig. 2. Ancillary ambulatory phlebectomy performed immediately after the EVLA procedure 
 
Fig. 3. Graduated compression stockings placed at the end of the procedure 
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Some patients will experience mild discomfort over the treated vein, beginning a few hours 
after the procedure that usually resolves in 24 to 48 hours and a nonsteroidal anti-
inflammatory drug may be taken daily as needed.  
2.4 Follow - up 
Clinical success after EVLA is defined as permanent occlusion of the treated vein segments 
with improvement in clinical syntomatology. Patients should return for periodic clinical and 
duplex ultrasound evaluation to confirm vein closure and exclude early complications. At 
minimum, patients should be examined at 1 week, 6 months and one year following laser 
ablation of the saphenous vein. But if a physician is trying to identify thrombus extension 
across the SPJ or SFJ, duplex ultrasound in the first 72 hours after EVLA should be 
performed. 
The natural history of a successfully treated truncal vein includes acute vein wall thickening 
without significant intraluminal thrombus in the first weeks after treatment followed over 
the next months by progressive vein shrinkage and eventual disappearance on ultrasound 
examination (Min et al 2003). This venous contraction, produces a delayed (4 to 6 weeks 
after the procedure) sensation described by the patient as “pulling”. This pain is most likely 
secondary to venous fibrosis as the treated vein undergoes permanent closure. Follow up 
duplex will no longer be needed when the treated vein is no longer visible.  
Additional periodic follow up may be necessary to evaluate the aetiology of any new 
tributary varicosities to determine whether they are related to a recurrence of reflux in the 
treated vein segment or progression of the disease in a different venous pathway. 
3. Clinical outcomes  
Sucess rates with EVLA of the GSV have generally been reported between 72% and 100%, 
and the follow up for these evaluations varies from 3 months to 4 years. Currently there is 
data from more than 60 publications with altogether more than 15000 EVLA treatments 
available. With the appropriate selection of patients, EVLA treatment can technically be 
carried out in more than 99 % of the patients. (Elmore, 2008) 
In a large single center, Myers and Jolley treated 509 limbs with an 810 nm laser during a 5 
year period. The rate of primary occlusion at 4 years was 76% and the secondary occlusion 
rate was 97%.( Myers et al 2009). A systematic review of EVLA for varicose veins by Mundy 
et al found an early saphenous occlusion rate of 88% to 100%. (Mundy et al 2005). 
There is fewer data for the SSV but the published results are qualitatively similar. 
Proebstle et al observed a 100% occlusion rate at 6 months by using 940 nm diode laser to 
treat SSV in 41 patients. (Proebstle et al 2008). In a prospective cohort study, Huisman et 
al treated the SSV in 169 limbs with an 810 nm diode laser. The treated length averaged 23 
cm (range 6 – 53 cm). Occlusion of the SSV after 3 months was achieved in 98%. (Huisman 
et al 2009) 
It has been reported that most incompletely ablated veins will develop reflux recurrence in 
the first few months following treatment. 
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Most EVLA recanalizations occur in the first 6 months, and all occurred in the first 12 
months. This has been interpreted as suggesting  that recanalization may be related to 
insufficient thermal energy delivered to the segment of the vein being treated. 
On the majority of the cases the 1-2 cm proximal segment of the vein below the SFJ or the 
SPJ remains patent. Inferior success rates of closure of this proximal vein segment may be 
related to an increased likelihood of insufficient thermal transfer to this portion that is 
usually  of larger caliber that the remaining vein, more difficult to empty, and less likely to 
develop spasm during tumescent anaesthetic administration. As a result, it is difficult to 
obtain device and vein wall apposition in this segment.  
There is a correlation between the amount of thermal energy delivered and the occlusion 
rate. Energy deposition has been described as the amount of energy delivered per 
centimetre of vein length (J/cm). Durable vein occlusion was demonstrated as more likely 
when the energy applied was a mean of 80 J/cm. (Sadick  et al 2004).  
As previously said successfully treated veins have been demonstrated to occlude and shrink 
with time. The average mean duration for a treated GSV to shrink to a fibrous cord of less 
than 2,5 mm diameter is 6 months.(Yang Ch 2006). 
Late clinical recurrence is extremely unlikely in an occluded vein that has shrunken to a 
non compressible cord. Based on this and on surgical data that demonstrates that the 
pathologic events that lead to recurrence usually take place within 2 years, later clinical 
recurrences are more likely related to development of incompetence in untreated veins. It 
seems that late clinical success after EVLA is predicted by the natural history of the 
venous insufficiency and the ability of the physician to identify and eliminate all 
incompetent pathways. 
Comparing two wavelengths of delivered laser energy  (940 nm and 1320 nm) in a 
retrospective analysis, showed equivalent occlusion rates, when used at similar rates of 
energy deposition. (Proebstle 2005)  
Several studies have documented significant and durable improvements in validated 
assessments of Quality of Life (QOL) following EVLA. Some studies demonstrated 
significant improvements in the Aberdeen Varicose Veins Questionnaire (AVVQ) as long as 
6 months following laser ablation. (Mekako et al 2006); (Rasmussen et al 2007) 
Ulcer healing has been reported after EVLA. One report documented an 84% success in 
ulcer healing with a combination of EVLA and microphlebectomy , with 77% of these 
healings occurring within 2 weeks after the procedure (Ravi et al 2006). 
Several studies have reported that EVLA is more effective than venous stripping and other 
endovenous procedures in terms of obliteration and lower recurrence rates in the range of 1 
to 5%. (Bos et al 2009) It is also important to mention that cosmetic results are in the majority 
of the cases very good when compared with high ligation and stripping. 
As with as other treatment options for superficial venous insufficiency, EVLA treatments 
and indications are in constant evolution. Neglen et al, demonstrated good outcomes 
combining laser ablation with deep vein stenting for superficial venous insufficiency and 
concomitant deep vein obstruction. (Neglen et al 2006) 
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As above indicated EVLA for the treatment of venous superficial reflux is an efficient 
treatment option. 
4. Complications 
Complications after EVLA may be divided into early and late complications (Table 2 and 3). 
The most serious potential complication involves misidentification of the anatomy with duplex 
ultrasound leading to the placement of the tip in a wrong position or even in a deep vein.  
 
Complications  
 
 
 
 
 
Early Complications 
Vessel Perforation 
Vein Spasm 
Vein Trombosis 
Excessive Pain 
Skin Burns 
Hematoma 
Hemorrhage 
Irrradiation of Nontarget tissue 
Thromboplhebitis 
Deep vein Thrombosis 
Pulmonary Embolism 
Arteriovenous fistula 
Table 2. Early complications of EVLA Procedure 
Complications  
Late Complications Recanalization of the Vein 
Skin Necrosis 
Paresthesia 
Infection 
Table 3. Late complications of EVLA Procedure 
In an international endovascular working group registry that included 3696 procedures, 
bruising after EVLA was observed in 75%  of the cases, paresthesia in 3%, thrombophlebitis 
in 1,87%, skin burns in 0,46% and DVT in 0,27% and there is a single report of pulmonary 
embolism (Kabnick et al 2006). But in majority of the series reported in the literature the 
complication rates are variable (Table 4). 
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Study Number of veins treated Complication Rate 
Navarro et al 40 Any 
Proebstle et al 41 6% thrombophlebitis 
Chang and Chua 252 1,6% thrombophlebitis 
36,5% paresthesia 
4,8% skin burn 
Timperman et al 111 1% deep vein thrombosis 
1% skin burn 
Huang et al 230 1% skin burn 
7% paresthesia 
Vuylsteke et al 118 4% skin burn 
14% paresthesia 
Almeida and Raines 819 0,2% deep vein thrombosis 
0,2% paresthesia 
2% thrombophlebitis 
Min et al 121 Any 
Meyers et al 404 0,2% severe pain 
Table 4. Complications after EVLA reported in the literature 
Ecchymosis (Figure 4) over the treated segment frequently occurs and normally can last 
approximately ten days. The mechanism of the EVLA procedure that causes ecchymosis 
remains unclear, although some experts speculate that these complications are due to 
perforation of the vein wall by laser energy.   
Superficial phlebitis is another uncommon side effect that is reported in approximately 5% 
of procedures (Min 2003). The major complications more frequently reported are neurologic 
injuries, skin burns and DVT. But the overall rate of these complications has been shown to 
be higher in low volume hospitals compared with high – volume hospitals. The nerves at 
highest risk include the saphenous nerve, adjacent to the GSV below the Knee and the Sural 
nerve adjacent to the SSV, but both of these nerves have only sensory components, and the 
most common manifestation of  nerve injury is paresthesia or dysthesia, which is often 
transient (Rutherford 2010). The nerve injury can occur with sheath and catheter 
introduction, during the delivery of tumescent anaesthesia, or by direct thermal injury. The 
rates of permanent paresthesias typically reported for laser are approximately 0-10% for 
GSV treatment. Only a few  series look at the SSV nerve injuries and the reported rates of 
temporary paresthesia following SSV EVLA are 0-10% in some series. It is reported that the 
rate of paresthesia is inversely related to the operator experience with perivenous 
ultrasound –guided anesthesia( Morrison  et al 2011). It has also been suggested that greater 
volumes of tumescence may be required during ablation of the SSV to prevent any thermal 
injury to the sural nerve which is in close proximity to the vein. 
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Fig. 4. Ecchymosis on the left lower limb after a bilateral EVLA procedure 
Skin burns following EVLA have been reported but are relatively rare and seem avoidable 
with adequate tumescent anesthesia. 
DVT following EVLA is unusual and can occur as an extension of thrombus formation from 
the treated truncal vein across the junctional connection into the deep vein or in the calf or 
femoral popliteal veins. The reported rates of junctional thrombosis following GSV EVLA 
are variable. This variability may relate to the ultrasound duplex timing after the EVLA 
procedure. Most series using early duplex ultrasound document a proximal thrombus 
extension of approximately 1% and those performing the ultrasound duplex later (after 72 
hours) identify a lower rate. But it is also possible that this different thrombus propagation 
rates are variable because the ultrasound is performed by different operators.  Data from 
different series suggests that the incidence of DVT is approximately of 0,3% after laser 
ablation. But this type of DVT is almost universally asymptomatic. The significance of this 
type of thrombus extension into the femoral vein seems to be different from the native deep 
vein thrombosis (Kabniick et al 2006). But treatment should be started immediately usually 
in an outpatient basis with compression, ambulation, anti – inflammatory medication and 
anticoagulation. A close follow up evaluation with ultrasound should be performed. 
Reports in  the literature based on careful follow up evaluation of these thrombo extensions 
concluded that they retract over the course of 7-10 days and none produced clinical 
symptoms suggestive of pulmonary embolus. (Morrison et al 2011). The incidence of 
junctional extension of thrombus after SSV ablation has been described to be inferior to 6 
%(Ravi et al 2006). In a particular study the rate of popliteal extension of SSV thrombus after 
EVLA was thought to be related to the anatomy of the SPJ (sapheno-popliteal junction) ( 
Gibson et al 2007). The incidence of DVT in other peripheral deep veins after EVLA has not 
been well evaluated. 
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There are some case reports in the literature of an arteriovenous fistula between a small 
popliteal artery branch and the SSV (Vaz et al 2008). Although thought to be related to a 
heat induced injury caused by thermal energy from the laser device, an a arteriovenous 
fistula could be caused by a needle injury during tumescent anaesthetic administration. To 
minimize the risk of these arteriovenous fistulas is necessary a careful advancement of the 
intravascular devices, atraumatic delivery of the tumescent fluid, the use of adequate 
amounts of tumescent fluid and the subfascial portion of the SSV where the popliteal artery 
branches exist, should be avoided. (figure 5). 
 
Fig. 5. Popliteal stage arteriography depicting an AV fistula between branches of the 
popliteal artery and a genicular vein after an EVLA procedure. 
If there is evidence of a perivenous structure (artery or nerve) that is impossible to isolate 
from the vein by the tumescent anesthesia, probably skipping this venous segment and 
use a combination of concomitant therapies would be a more prudent choice( Perrin et al 
2007). 
During the procedure, adverse patient events may occur, which are rarely reported. A 
transient vagal reaction is often described secondary to the patient’s anxiety, there are some 
reports of dysrhytmia and transient pain due to inadequate anesthetic infiltration. 
Infection is extremely rare, but there is one case report of septic thrombophlebitis following 
an EVLA procedure requiring surgical intervention (Dunst et al 2006). 
Neovascularization has been reported only in one case on the literature three years after the 
EVLA procedure (Morrison et al 2011). The endovenous laser ablation procedure 
deliberately leaves the superficial epigastric vein intact, which, it is believed, has contributed 
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to the lack of neovascularisation reported so far. More case reports are necessary to establish 
a mechanism of this type of neovascularisation after an EVLA procedure. 
Laser fracture or retained venous access sheaths have been reported on the literature (Ravi 
et al 2007).Caution in handling the laser should help to minimize these situations, and the 
possibility of a laser fracture should always be considered with the removal of the device. 
Care to deliver thermal energy only beyond the introducer is essential to avoid damage of 
some segments of these catheters. 
Some evidence suggests that higher wavelength lasers produce less pain and bruising as 
well as minimize other types of complications; however a large scale study evaluating all 
wavelengths available is needed to confirm these initial findings. 
A new adaptation of the laser fibbers has emerged,that appears to have some beneficial 
effect on the vein wall perforation, the jacket tipped fibers. This newly advance constitutes 
on a stainless steel or a ceramic jacket that completely covers the tip of the fiber, with the 
end of the tip being recessed within the jacket, thus preventing the tip contact with the vein 
wall. One study has been described on the literature comparing the efficacy and the 
complications of jacket tipped fibers versus bare tipped fibers. At 72 hours after the 
procedure, both groups demonstrated 100% success treatment and in the jacket tipped 
group pain and ecchymoses scores appeared to be lower. 
5. Discussion 
Endovascular techniques have been introduced as minimally invasive alternatives to high 
ligation and open surgical stripping of the incompetent GSV or SSV. The Endovenous laser 
therapy has established itself in the last few years among the range of endovascular therapy 
options for the treatment of truncal vein insufficiency. Nevertheless the significance of this 
reflux in itself still remains a matter of debate. A duplex ultrasound detected reflux should 
not be in itself an indication for treatment. We think that EVLA, as well as other treatment 
modalities, is only indicated in patients with clear symptoms and clinical signs of chronic 
venous insufficiency (varicose veins, skin changes or ulcer).  
Studies looking specifically at the success and complication rates associated with laser 
ablation are extensively being reported. But the effects of laser on tissue, and therefore on 
clinical results, are clearly very variable because of the use of different wavelengths, 
different pull back protocols and different energy densities and so EVLA can hardly be 
standardized. Mechanisms to determine the accurate energy density to be used in EVLA are 
lacking. This makes the appropriate dosage of light for the sufficient thermal alteration of 
tissue harder to achieve. In addition to transmural damage, wall perforation is being 
reported with great variability in most of the series. 
In order to eliminate these disadvantages and create endothermal occlusion more effectively 
and in a more reproducible fashion, EVLA continues to find itself in a dynamic process of 
development. Treatment planning, technical details and postprocedural care is of 
paramount importance to this procedure and to the operator. Every patient undergoing 
endovenous procedures should do an early post-operative duplex scan to rule out major 
complications (Perrin et al 2007). The learning curve in EVLA treatment of the SSV is still 
going up, and further experience and research with this modality will better delineate its 
risks, complications and long term efficacy. 
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6. Conclusion  
The Endovascular technology has transformed the evaluation and treatment of venous 
disease during the past decade. As with any new technique, there is a learning curve in 
terms of patient selection and the different steps of the procedure itself. Once mastered it 
seems that EVLA can safely eradicate GSV and SSV reflux with a low rate of minor 
complications and a lower rate of major complications.  
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